Trade ABVC anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
ABVC BioPharma, Inc. (ABVC) is trading at US$0.82, up 3.18% today as of Aug 28, 10:56 EDT. The company has a market capitalisation of US$23.72M. Over the past 52 weeks, ABVC has traded between US$0.71 and US$3.40. On Syfe you can trade ABVC with $0 commission and add it to your watchlist.
| Previous close | US$0.80 |
|---|---|
| Market cap | US$23.72M |
| 52-week range | US$0.71 – US$3.40 |
| Volume | 127.81K |
| Exchange | US |
Add to Watchlist
Set Price Alert
ABVC BioPharma, Inc.
ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The firm's product pipeline includes ABV-1501, which is a combination therapy for triple negative breast cancer, ABV-1504, which is a botanical reuptake inhibitor that targets norepinephrine, ABV-1505 for treating attention deficit hyperactivity disorder, ABV-1702 to treat myelodysplastic syndromes, ABV-1703 for Pancreatic Cancer, ABV-1601 for treating depression in cancer patients, ABV-1701, which is a vitreous substitute for vitrectomy, ABV-2001, and ABV-2002. The company was founded in 1990 and is headquartered in Fremont, CA.
Year: 2004
ABVC BioPharma, Inc. (ABVC) stock is trading at US$0.82, +3.18% from the previous close of US$0.80.
The market cap for ABVC BioPharma, Inc. (ABVC) stock is approximately US$23.72M.
The 52-week high for ABVC BioPharma, Inc. (ABVC) stock is US$3.40.
The 52-week low for ABVC BioPharma, Inc. (ABVC) stock is US$0.71.
ABVC BioPharma, Inc. (ABVC) does not currently pay a dividend.
Stay on top of ABVC
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
